The standard for medical development
Pioneering Medical Advances
We are a science led global healthcare company looking towards the future. Cannsun has always been on the cutting edge of pharmaceuticals and healthcare, marked by a tradition of producing the latest in medical innovation. Today, Cannsun continues to grow and develop pharmaceutical solutions while merging traditional medicines to include cannabinoid alternatives.
Cannsun is Europe’s first medical manufacturer
with a vertically integrated cannabinoid division.
A Vision for the Future
The recent developments in cannabinoids have illustrated that their potential is endless and untapped. Cannsunn is dedicated to the production of high-quality healthcare, medical and wellness products that it has always been known for, in addition to providing the latest in medical cannabinoid development. Cannabis development is one of the fastest growing healthcare markets globally, and Cannsun is perfectly positioned to produce the latest products in line with these developments.
Heath & Wellness Medicine
Cannsun seeks to enhance the lives people around the world by producing the highest quality, natural, pure African and Greek cannabinoids and botanicals, providing state of the art medical solutions. Our projected growth indicates that we will be the largest cultivator of medical grade cannabis plants in Africa and Southern Europe, positioning us uniquely to provide cutting edge bio-cannabinoid medical solutions. Cannsun has extensive expertise and proven a track record in bringing a product in healthcare market.
Cannsun continues to grow and develop pharmaceutical model while merging traditional medicines to include cannabinoid alternatives for treatments of:
Management & Directors
Chief Executive Officer
Co-Founder of Cannsun South Africa and Chief Executive Officer of the Cannsun Medhel Group. David is also a Director of Propagation Services Canada one of the largest Cannabis facilities under glass in Canada, and Former Managing Director of Natures Hemp Ltd in Canada, a company developing food-based hemp products with the University of Manitoba and the Ontario Government. David has over 20 years working with public and private companies in the agriculture, resource and technology sectors. He has an extensive network of contacts and relationships throughout MENA, Europe, the Former Soviet Union (FSU), Asia and Africa with significant experience in mergers and acquisitions.
Chief Operating Officer
Aaron is a professional engineer holding a BSc Engineering from the University of Alberta, Canada. Aaron has 11 years experience in oil & gas specializing in project management with recent focus in acquisitions and dispositions (closing and integrating $100+ million-dollars in transactions). More recently Aaron held a position with Vibe Bioscience as Vice President of Business Development, facilitated in the process of taking Vibe public in Spring 2019 listing on the Canadian Securities Exchange. Aaron’s core focus at Vibe was product development (THC and CBD concentrates), retail, cultivation and evaluating acquisition opportunities. He has spent four years directly involved in the cannabis space with investment in cultivation, US retail and e-commerce companies both private and public.
Head of Women’s Health & Chief Science Officer
Co-Founder and Head of Africa
Director & General Counsel
Dr. Michel Georges Magouritsas
Director of Finance
Quality Assurance Director
Theodoros is a graduate from the University of Patras specializing in Biochemistry & Biotechnology. Theodoros was born in Vonitsa, Greece and currently holds position as Quality Assurance Director. He has over 15 years experience in management positions in the pharmaceutical sector. Theodoros has held positions in Quality Assurance and as a Qualified person for companies such as Uni Pharma S.A. and Layipharm S.A.
Head of Operations Thailand
Bhunyanee is a Thailand-based Chemist who has built a career working for Thailand and Italian based companies. The previous 17 years she has been with Eagle Chemical IND. of Thailand and Alpa SPA of Italy in roles from Research and Development Officer, Sales and Chief Operating Officer. In her role at Cannsun Medhel Group, Bhunyanee will directly support both the CEO and COO. She is a graduate of Sukhothai Thamathirat (Technology) University in 2002. Over the past several years, Bhunyanee has been in the Cannabis space making Bespoke cosmetics and natural medicine. She has been key figure in the project development in Asia.